New weight loss drug ‘game changer’ as participants lose 15kg in obesity trial

Obesity: Appetite-suppressant drug ‘breakthrough’ revealed

When you subscribe we will use the information you provide to send you these newsletters.Sometimes they’ll include recommendations for other related newsletters or services we offer.Our Privacy Notice explains more about how we use your data, and your rights.You can unsubscribe at any time.

The appetite-suppressing drug, semaglutide, caused 75 percent of participants to lose more than 10 percent of their body weight. Even more impressive, 35 percent of those involved in the trial lost more than 20 percent of their body weight. The average participant lost 15kg – around two-and-a-half stone – from taking semaglutide. This is the first time medicine has achieved such ground-breaking results, once only thought possible through surgery.

DON’T MISS 
South Africa variant: The 15 possible warning signs [INSIGHT]
Covid new strain: Four unusual symptoms [ADVICE]
Apple cider vinegar: How much you need to see benefits [TIPS]

Source: Read Full Article